MediPharm Labs responds to allegations from dissident shareholder Apollo, intentionally or recklessly fabricated as part of its campaign of misinformation.

TORONTO, May 29, 2025 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE:MLZ) (MediPharm or the Company), a pharmaceutical company specialized in precision-based cannabinoids, t…